July 2021

COVID-19 Cognitive Assessment Battery

Insights Back to resource centre 13 July 2021 COVID-19 Cognitive Assessment Battery To understand the impact of COVID-19 on cognitive function, researchers must use sensitive and reliable cognitive assessments which target appropriate domains. In this article Operational Scientist, Iona Pickett, discusses the challenges of designing a cognitive testing battery for use in those recovering from COVID-19 and describes our recommended

COVID-19 Cognitive Assessment Battery Read More »

Voice Technology in Clinical Trials

Webinars Back to resource centre 11 January 2023 Voice Technology in Clinical Trials Forecasts suggest that by 2024 the number of digital voice assistants will reach 8.4 billion units – a number higher than the world’s population. However, as these devices are built for commands rather than cognitive testing, how can clinical trials benefit from the technology? In this webinar,

Voice Technology in Clinical Trials Read More »

Spin-out of Monument Therapeutics

Insights Back to resource centre 1 July 2021 Spin-out of Monument Therapeutics Cambridge Cognition is pleased to announce the completion of the spin-out of Monument Therapeutics, a drug development company applying digital phenotyping to central nervous system (“CNS”) disorders. Cambridge Cognition has been incubating Monument Therapeutics since 2018, with early-stage research supported by two Innovate UK grants. Monument Therapeutics applies

Spin-out of Monument Therapeutics Read More »

Spin-out of Monument Therapeutics

News Back to resource centre 1 July 2021 Spin-out of Monument Therapeutics Cambridge Cognition is pleased to announce the completion of the spin-out of Monument Therapeutics, a drug development company applying digital phenotyping to central nervous system (“CNS”) disorders.Cambridge Cognition has been incubating Monument Therapeutics since 2018, with early-stage research supported by two Innovate UK grants. Monument Therapeutics applies a novel drug development

Spin-out of Monument Therapeutics Read More »

Scroll to Top